Renowned Neurosurgeon, Andrew Parsa, Joins Northwestern
Andrew Parsa, MD, PhD, an internationally-renowned neurosurgeon specializing in complex tumors of the brain and spine, will join Northwestern Brain Tumor Institute and the Feinberg School of Medicine on July 1 as the Michael J. Marchese Professor and Chair of the Department of Neurological Surgery.
“Dr. Parsa is a pioneering neurosurgeon and innovative scientist whose addition to Northwestern Medicine strengthens our position as a leader in the investigation of neurological cancers,” said Eric G. Neilson, MD, Vice President for Medical Affairs and Lewis Landsberg Dean.
For the past decade, Parsa has been at the University of California San Francisco (UCSF), most recently as Professor, Vice Chair, and Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery.
“I am truly excited to embark upon this next stage of my career, which will allow me to impact neurosurgery more broadly,” Parsa said. “I will have a unique opportunity to positively shape the training of residents and the development of faculty in neurosurgery at one of the most respected institutions in the country.”
Continuously supported by the NIH since 2002, Parsa’s research on brain tumor immunology has provided landmark insights, including the identification of a novel link between oncogenesis and immune-resistance in brain tumors. He is currently the study chair for the largest randomized brain tumor vaccine trial ever to be funded by the National Cancer Institute.